Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Henry Meds vs June Health

By GLP-1 ScorecardUpdated

Henry Meds
Site position #47

Higher score

June HealthFactor scores not reassessed.
Site position #283

Lower score

Score comparison

Henry Meds has the higher recorded score — 77.3/100 to 63/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.

Before you choose

Before comparing the headline prices, the Henry Meds review and the June Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Henry Meds vs Longevixx and June Health vs MEDGm compare each of them with another graded program, and the list of alternatives to Henry Meds ranks the programs closest to Henry Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueHenry Meds +11
72
61
Dose & formulationHenry Meds +5
80
75
Clinical oversightHenry Meds +21
80
59
Labs & monitoringHenry Meds +27
78
51
FulfillmentHenry Meds +4
78
74
Contract termsHenry Meds +23
78
55
Henry Meds · top barJune Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricHenry MedsJune Health
WeighScore77.3/10063/100
GradeC+C
Site position#47#283
Semaglutide$197/mo (injectable; 12-month plan paid upfront in full, $2,364)From $279/mo for injections (tablets from $187/mo; compounded)
TirzepatideOral compounded plans; confirm selected price and supplyFrom $409/mo for injections (tablets from $249/mo; compounded)
CoverageMulti-stateCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Henry Meds

Site position #47 · C+

Strengths

  • Published plan prices identify their upfront-payment requirement
  • Medication, provider access, applicable supplies and shipping included if prescribed
  • Compounded injectable semaglutide and oral options listed

What to consider

  • The $197 semaglutide headline requires $2,364 upfront, not monthly payments
  • Oral program headings and supply descriptions conflict; obtain the selected written quote
  • Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
June Health

Site position #283 · C

Factor scores not reassessed.

Strengths

  • Offers both injectable and oral compounded semaglutide and tirzepatide
  • Semaglutide injections from $279/mo or tablets from $187/mo; tirzepatide injections from $409/mo or tablets from $249/mo
  • Full per-dose price list published on-site with no signup required to view it
  • Provider consult ('licensed clinician evaluation') is bundled into the displayed price
  • Free discreet shipping advertised with 2-3 day delivery

What to consider

  • No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
  • No LegitScript seal or other pharmacy-verification badge found anywhere on the site
  • Legal entity, prescribing medical group, and compounding pharmacy partner are not named
  • Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
  • Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard